aluates Reports

$ 0.0

Automative

Global Transdermal Drug Delivery System Market Research Report 2026

Published Date: 2026-02-10

Report Code: QYRE-Auto-36I603

Global Transdermal Drug Delivery System Market Insights and Forecast to 2028

BUY CHAPTERS

Global Transdermal Drug Delivery System Market Research Report 2026

Code: QYRE-Auto-36I603

Report

2026-02-10

Pages:135

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Hisamitsu

Mylan NV

GSK

Novartis

Teve (Actavis)

Johnson & Johnson

Lohmann

TEIKOKU SEIYAKU

Bayer

Lingrui

Sanofi

Qizheng

Endo

Huarun 999

Haw Par

Nichiban

Mentholatum

Laboratoires Genevrier

Johnson & Johnson

Transdermal Drug Delivery System Market Size

The global Transdermal Drug Delivery System market was valued at US$ 21610 million in 2025 and is anticipated to reach US$ 39120 million by 2032, at a CAGR of 9.0% from 2026 to 2032.

Transdermal Drug Delivery System Market

Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.

The transdermal drug delivery system (TDDS) market is driven by the increasing demand for non-invasive, convenient, and controlled drug administration methods. TDDS allows drugs to be delivered through the skin, bypassing the gastrointestinal tract and liver, which can reduce side effects and improve bioavailability. This method is especially beneficial for patients who have difficulty swallowing pills, those requiring continuous drug delivery, and individuals with chronic conditions like pain, hypertension, or diabetes. The market is also driven by advancements in technology, such as the development of better adhesive patches, microneedles, and nanocarriers, which enhance the efficiency and precision of drug delivery. These innovations are expanding the scope of TDDS applications, offering a wide range of therapeutic options.

Despite its growth, the transdermal drug delivery system market faces several challenges. One major limitation is the skin's barrier function, which restricts the absorption of larger or hydrophilic molecules, making it difficult to deliver certain drugs transdermally. Additionally, the high cost of developing and manufacturing TDDS products, as well as the need for specialized formulations, can deter smaller pharmaceutical companies from entering the market. Regulatory hurdles and concerns over the safety, efficacy, and long-term stability of transdermal formulations also present challenges. Furthermore, patient acceptance and the potential for skin irritation or allergic reactions to the adhesive components of TDDS patches may limit their widespread adoption.

This report delivers a comprehensive overview of the global Transdermal Drug Delivery System market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Transdermal Drug Delivery System. The Transdermal Drug Delivery System market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Transdermal Drug Delivery System market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Transdermal Drug Delivery System manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Transdermal Drug Delivery System Market Report

Report Metric	Details
Report Name	Transdermal Drug Delivery System Market
Accounted market size in 2025	US$ 21610 million
Forecasted market size in 2032	US$ 39120 million
CAGR	9.0%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Fentanyl Nitroglycerin Estradiol Nicotine Other
Segment by Application	OTC Rx
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Hisamitsu, Mylan, GSK, Novartis, Teve (Actavis), Johnson & Johnson, Lohmann, Teikoku Seiyaku, Bayer, Lingrui, Sanofi, Qizheng, Endo, Huarun 999, Haw Par, Nichiban, Mentholatum, Laboratoires Genevrier
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Transdermal Drug Delivery System companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Transdermal Drug Delivery System Market growing?

Ans: The Transdermal Drug Delivery System Market witnessing a CAGR of 9.0% during the forecast period 2026-2032.

What is the Transdermal Drug Delivery System Market size in 2032?

Ans: The Transdermal Drug Delivery System Market size in 2032 will be US$ 39120 million.

Who are the main players in the Transdermal Drug Delivery System Market report?

Ans: The main players in the Transdermal Drug Delivery System Market are Hisamitsu, Mylan, GSK, Novartis, Teve (Actavis), Johnson & Johnson, Lohmann, Teikoku Seiyaku, Bayer, Lingrui, Sanofi, Qizheng, Endo, Huarun 999, Haw Par, Nichiban, Mentholatum, Laboratoires Genevrier

What are the Application segmentation covered in the Transdermal Drug Delivery System Market report?

Ans: The Applications covered in the Transdermal Drug Delivery System Market report are OTC, Rx

What are the Type segmentation covered in the Transdermal Drug Delivery System Market report?

Ans: The Types covered in the Transdermal Drug Delivery System Market report are Fentanyl, Nitroglycerin, Estradiol, Nicotine, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Transdermal Drug Delivery System Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Fentanyl

1.2.3 Nitroglycerin

1.2.4 Estradiol

1.2.5 Nicotine

1.2.6 Other

1.3 Market by Application

1.3.1 Global Transdermal Drug Delivery System Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 OTC

1.3.3 Rx

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Transdermal Drug Delivery System Market Perspective (2021–2032)

2.2 Global Transdermal Drug Delivery System Growth Trends by Region

2.2.1 Global Transdermal Drug Delivery System Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Transdermal Drug Delivery System Historic Market Size by Region (2021–2026)

2.2.3 Transdermal Drug Delivery System Forecasted Market Size by Region (2027–2032)

2.3 Transdermal Drug Delivery System Market Dynamics

2.3.1 Transdermal Drug Delivery System Industry Trends

2.3.2 Transdermal Drug Delivery System Market Drivers

2.3.3 Transdermal Drug Delivery System Market Challenges

2.3.4 Transdermal Drug Delivery System Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Transdermal Drug Delivery System Players by Revenue

3.1.1 Global Top Transdermal Drug Delivery System Players by Revenue (2021–2026)

3.1.2 Global Transdermal Drug Delivery System Revenue Market Share by Players (2021–2026)

3.2 Global Top Transdermal Drug Delivery System Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Transdermal Drug Delivery System Revenue

3.4 Global Transdermal Drug Delivery System Market Concentration Ratio

3.4.1 Global Transdermal Drug Delivery System Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Transdermal Drug Delivery System Revenue in 2025

3.5 Global Key Players of Transdermal Drug Delivery System Head Offices and Areas Served

3.6 Global Key Players of Transdermal Drug Delivery System, Products and Applications

3.7 Global Key Players of Transdermal Drug Delivery System, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Transdermal Drug Delivery System Breakdown Data by Type

4.1 Global Transdermal Drug Delivery System Historic Market Size by Type (2021–2026)

4.2 Global Transdermal Drug Delivery System Forecasted Market Size by Type (2027–2032)

5 Transdermal Drug Delivery System Breakdown Data by Application

5.1 Global Transdermal Drug Delivery System Historic Market Size by Application (2021–2026)

5.2 Global Transdermal Drug Delivery System Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Transdermal Drug Delivery System Market Size (2021–2032)

6.2 North America Transdermal Drug Delivery System Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Transdermal Drug Delivery System Market Size by Country (2021–2026)

6.4 North America Transdermal Drug Delivery System Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Transdermal Drug Delivery System Market Size (2021–2032)

7.2 Europe Transdermal Drug Delivery System Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Transdermal Drug Delivery System Market Size by Country (2021–2026)

7.4 Europe Transdermal Drug Delivery System Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Transdermal Drug Delivery System Market Size (2021–2032)

8.2 Asia-Pacific Transdermal Drug Delivery System Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Transdermal Drug Delivery System Market Size by Region (2021–2026)

8.4 Asia-Pacific Transdermal Drug Delivery System Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Transdermal Drug Delivery System Market Size (2021–2032)

9.2 Latin America Transdermal Drug Delivery System Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Transdermal Drug Delivery System Market Size by Country (2021–2026)

9.4 Latin America Transdermal Drug Delivery System Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Transdermal Drug Delivery System Market Size (2021–2032)

10.2 Middle East & Africa Transdermal Drug Delivery System Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Transdermal Drug Delivery System Market Size by Country (2021–2026)

10.4 Middle East & Africa Transdermal Drug Delivery System Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Hisamitsu

11.1.1 Hisamitsu Company Details

11.1.2 Hisamitsu Business Overview

11.1.3 Hisamitsu Transdermal Drug Delivery System Introduction

11.1.4 Hisamitsu Revenue in Transdermal Drug Delivery System Business (2021–2026)

11.1.5 Hisamitsu Recent Development

11.2 Mylan

11.2.1 Mylan Company Details

11.2.2 Mylan Business Overview

11.2.3 Mylan Transdermal Drug Delivery System Introduction

11.2.4 Mylan Revenue in Transdermal Drug Delivery System Business (2021–2026)

11.2.5 Mylan Recent Development

11.3 GSK

11.3.1 GSK Company Details

11.3.2 GSK Business Overview

11.3.3 GSK Transdermal Drug Delivery System Introduction

11.3.4 GSK Revenue in Transdermal Drug Delivery System Business (2021–2026)

11.3.5 GSK Recent Development

11.4 Novartis

11.4.1 Novartis Company Details

11.4.2 Novartis Business Overview

11.4.3 Novartis Transdermal Drug Delivery System Introduction

11.4.4 Novartis Revenue in Transdermal Drug Delivery System Business (2021–2026)

11.4.5 Novartis Recent Development

11.5 Teve (Actavis)

11.5.1 Teve (Actavis) Company Details

11.5.2 Teve (Actavis) Business Overview

11.5.3 Teve (Actavis) Transdermal Drug Delivery System Introduction

11.5.4 Teve (Actavis) Revenue in Transdermal Drug Delivery System Business (2021–2026)

11.5.5 Teve (Actavis) Recent Development

11.6 Johnson & Johnson

11.6.1 Johnson & Johnson Company Details

11.6.2 Johnson & Johnson Business Overview

11.6.3 Johnson & Johnson Transdermal Drug Delivery System Introduction

11.6.4 Johnson & Johnson Revenue in Transdermal Drug Delivery System Business (2021–2026)

11.6.5 Johnson & Johnson Recent Development

11.7 Lohmann

11.7.1 Lohmann Company Details

11.7.2 Lohmann Business Overview

11.7.3 Lohmann Transdermal Drug Delivery System Introduction

11.7.4 Lohmann Revenue in Transdermal Drug Delivery System Business (2021–2026)

11.7.5 Lohmann Recent Development

11.8 Teikoku Seiyaku

11.8.1 Teikoku Seiyaku Company Details

11.8.2 Teikoku Seiyaku Business Overview

11.8.3 Teikoku Seiyaku Transdermal Drug Delivery System Introduction

11.8.4 Teikoku Seiyaku Revenue in Transdermal Drug Delivery System Business (2021–2026)

11.8.5 Teikoku Seiyaku Recent Development

11.9 Bayer

11.9.1 Bayer Company Details

11.9.2 Bayer Business Overview

11.9.3 Bayer Transdermal Drug Delivery System Introduction

11.9.4 Bayer Revenue in Transdermal Drug Delivery System Business (2021–2026)

11.9.5 Bayer Recent Development

11.10 Lingrui

11.10.1 Lingrui Company Details

11.10.2 Lingrui Business Overview

11.10.3 Lingrui Transdermal Drug Delivery System Introduction

11.10.4 Lingrui Revenue in Transdermal Drug Delivery System Business (2021–2026)

11.10.5 Lingrui Recent Development

11.11 Sanofi

11.11.1 Sanofi Company Details

11.11.2 Sanofi Business Overview

11.11.3 Sanofi Transdermal Drug Delivery System Introduction

11.11.4 Sanofi Revenue in Transdermal Drug Delivery System Business (2021–2026)

11.11.5 Sanofi Recent Development

11.12 Qizheng

11.12.1 Qizheng Company Details

11.12.2 Qizheng Business Overview

11.12.3 Qizheng Transdermal Drug Delivery System Introduction

11.12.4 Qizheng Revenue in Transdermal Drug Delivery System Business (2021–2026)

11.12.5 Qizheng Recent Development

11.13 Endo

11.13.1 Endo Company Details

11.13.2 Endo Business Overview

11.13.3 Endo Transdermal Drug Delivery System Introduction

11.13.4 Endo Revenue in Transdermal Drug Delivery System Business (2021–2026)

11.13.5 Endo Recent Development

11.14 Huarun 999

11.14.1 Huarun 999 Company Details

11.14.2 Huarun 999 Business Overview

11.14.3 Huarun 999 Transdermal Drug Delivery System Introduction

11.14.4 Huarun 999 Revenue in Transdermal Drug Delivery System Business (2021–2026)

11.14.5 Huarun 999 Recent Development

11.15 Haw Par

11.15.1 Haw Par Company Details

11.15.2 Haw Par Business Overview

11.15.3 Haw Par Transdermal Drug Delivery System Introduction

11.15.4 Haw Par Revenue in Transdermal Drug Delivery System Business (2021–2026)

11.15.5 Haw Par Recent Development

11.16 Nichiban

11.16.1 Nichiban Company Details

11.16.2 Nichiban Business Overview

11.16.3 Nichiban Transdermal Drug Delivery System Introduction

11.16.4 Nichiban Revenue in Transdermal Drug Delivery System Business (2021–2026)

11.16.5 Nichiban Recent Development

11.17 Mentholatum

11.17.1 Mentholatum Company Details

11.17.2 Mentholatum Business Overview

11.17.3 Mentholatum Transdermal Drug Delivery System Introduction

11.17.4 Mentholatum Revenue in Transdermal Drug Delivery System Business (2021–2026)

11.17.5 Mentholatum Recent Development

11.18 Laboratoires Genevrier

11.18.1 Laboratoires Genevrier Company Details

11.18.2 Laboratoires Genevrier Business Overview

11.18.3 Laboratoires Genevrier Transdermal Drug Delivery System Introduction

11.18.4 Laboratoires Genevrier Revenue in Transdermal Drug Delivery System Business (2021–2026)

11.18.5 Laboratoires Genevrier Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Hisamitsu

Mylan NV

GSK

Novartis

Teve (Actavis)

Johnson & Johnson

Lohmann

TEIKOKU SEIYAKU

Bayer

Lingrui

Sanofi

Qizheng

Endo

Huarun 999

Haw Par

Nichiban

Mentholatum

Laboratoires Genevrier

Johnson & Johnson

List of Tables

Table 1. Global Transdermal Drug Delivery System Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Fentanyl

Table 3. Key Players of Nitroglycerin

Table 4. Key Players of Estradiol

Table 5. Key Players of Nicotine

Table 6. Key Players of Other

Table 7. Global Transdermal Drug Delivery System Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 8. Global Transdermal Drug Delivery System Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 9. Global Transdermal Drug Delivery System Market Size by Region (US$ Million), 2021–2026

Table 10. Global Transdermal Drug Delivery System Market Share by Region (2021–2026)

Table 11. Global Transdermal Drug Delivery System Forecasted Market Size by Region (US$ Million), 2027–2032

Table 12. Global Transdermal Drug Delivery System Market Share by Region (2027–2032)

Table 13. Transdermal Drug Delivery System Market Trends

Table 14. Transdermal Drug Delivery System Market Drivers

Table 15. Transdermal Drug Delivery System Market Challenges

Table 16. Transdermal Drug Delivery System Market Restraints

Table 17. Global Transdermal Drug Delivery System Revenue by Players (US$ Million), 2021–2026

Table 18. Global Transdermal Drug Delivery System Market Share by Players (2021–2026)

Table 19. Global Top Transdermal Drug Delivery System Players by Tier (Tier 1, Tier 2, and Tier 3), based on Transdermal Drug Delivery System Revenue, 2025

Table 20. Ranking of Global Top Transdermal Drug Delivery System Companies by Revenue (US$ Million) in 2025

Table 21. Global 5 Largest Players Market Share by Transdermal Drug Delivery System Revenue (CR5 and HHI), 2021–2026

Table 22. Global Key Players of Transdermal Drug Delivery System, Headquarters and Area Served

Table 23. Global Key Players of Transdermal Drug Delivery System, Products and Applications

Table 24. Global Key Players of Transdermal Drug Delivery System, Date of General Availability (GA)

Table 25. Mergers and Acquisitions, Expansion Plans

Table 26. Global Transdermal Drug Delivery System Market Size by Type (US$ Million), 2021–2026

Table 27. Global Transdermal Drug Delivery System Revenue Market Share by Type (2021–2026)

Table 28. Global Transdermal Drug Delivery System Forecasted Market Size by Type (US$ Million), 2027–2032

Table 29. Global Transdermal Drug Delivery System Revenue Market Share by Type (2027–2032)

Table 30. Global Transdermal Drug Delivery System Market Size by Application (US$ Million), 2021–2026

Table 31. Global Transdermal Drug Delivery System Revenue Market Share by Application (2021–2026)

Table 32. Global Transdermal Drug Delivery System Forecasted Market Size by Application (US$ Million), 2027–2032

Table 33. Global Transdermal Drug Delivery System Revenue Market Share by Application (2027–2032)

Table 34. North America Transdermal Drug Delivery System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 35. North America Transdermal Drug Delivery System Market Size by Country (US$ Million), 2021–2026

Table 36. North America Transdermal Drug Delivery System Market Size by Country (US$ Million), 2027–2032

Table 37. Europe Transdermal Drug Delivery System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 38. Europe Transdermal Drug Delivery System Market Size by Country (US$ Million), 2021–2026

Table 39. Europe Transdermal Drug Delivery System Market Size by Country (US$ Million), 2027–2032

Table 40. Asia-Pacific Transdermal Drug Delivery System Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 41. Asia-Pacific Transdermal Drug Delivery System Market Size by Region (US$ Million), 2021–2026

Table 42. Asia-Pacific Transdermal Drug Delivery System Market Size by Region (US$ Million), 2027–2032

Table 43. Latin America Transdermal Drug Delivery System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Latin America Transdermal Drug Delivery System Market Size by Country (US$ Million), 2021–2026

Table 45. Latin America Transdermal Drug Delivery System Market Size by Country (US$ Million), 2027–2032

Table 46. Middle East & Africa Transdermal Drug Delivery System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 47. Middle East & Africa Transdermal Drug Delivery System Market Size by Country (US$ Million), 2021–2026

Table 48. Middle East & Africa Transdermal Drug Delivery System Market Size by Country (US$ Million), 2027–2032

Table 49. Hisamitsu Company Details

Table 50. Hisamitsu Business Overview

Table 51. Hisamitsu Transdermal Drug Delivery System Product

Table 52. Hisamitsu Revenue in Transdermal Drug Delivery System Business (US$ Million), 2021–2026

Table 53. Hisamitsu Recent Development

Table 54. Mylan Company Details

Table 55. Mylan Business Overview

Table 56. Mylan Transdermal Drug Delivery System Product

Table 57. Mylan Revenue in Transdermal Drug Delivery System Business (US$ Million), 2021–2026

Table 58. Mylan Recent Development

Table 59. GSK Company Details

Table 60. GSK Business Overview

Table 61. GSK Transdermal Drug Delivery System Product

Table 62. GSK Revenue in Transdermal Drug Delivery System Business (US$ Million), 2021–2026

Table 63. GSK Recent Development

Table 64. Novartis Company Details

Table 65. Novartis Business Overview

Table 66. Novartis Transdermal Drug Delivery System Product

Table 67. Novartis Revenue in Transdermal Drug Delivery System Business (US$ Million), 2021–2026

Table 68. Novartis Recent Development

Table 69. Teve (Actavis) Company Details

Table 70. Teve (Actavis) Business Overview

Table 71. Teve (Actavis) Transdermal Drug Delivery System Product

Table 72. Teve (Actavis) Revenue in Transdermal Drug Delivery System Business (US$ Million), 2021–2026

Table 73. Teve (Actavis) Recent Development

Table 74. Johnson & Johnson Company Details

Table 75. Johnson & Johnson Business Overview

Table 76. Johnson & Johnson Transdermal Drug Delivery System Product

Table 77. Johnson & Johnson Revenue in Transdermal Drug Delivery System Business (US$ Million), 2021–2026

Table 78. Johnson & Johnson Recent Development

Table 79. Lohmann Company Details

Table 80. Lohmann Business Overview

Table 81. Lohmann Transdermal Drug Delivery System Product

Table 82. Lohmann Revenue in Transdermal Drug Delivery System Business (US$ Million), 2021–2026

Table 83. Lohmann Recent Development

Table 84. Teikoku Seiyaku Company Details

Table 85. Teikoku Seiyaku Business Overview

Table 86. Teikoku Seiyaku Transdermal Drug Delivery System Product

Table 87. Teikoku Seiyaku Revenue in Transdermal Drug Delivery System Business (US$ Million), 2021–2026

Table 88. Teikoku Seiyaku Recent Development

Table 89. Bayer Company Details

Table 90. Bayer Business Overview

Table 91. Bayer Transdermal Drug Delivery System Product

Table 92. Bayer Revenue in Transdermal Drug Delivery System Business (US$ Million), 2021–2026

Table 93. Bayer Recent Development

Table 94. Lingrui Company Details

Table 95. Lingrui Business Overview

Table 96. Lingrui Transdermal Drug Delivery System Product

Table 97. Lingrui Revenue in Transdermal Drug Delivery System Business (US$ Million), 2021–2026

Table 98. Lingrui Recent Development

Table 99. Sanofi Company Details

Table 100. Sanofi Business Overview

Table 101. Sanofi Transdermal Drug Delivery System Product

Table 102. Sanofi Revenue in Transdermal Drug Delivery System Business (US$ Million), 2021–2026

Table 103. Sanofi Recent Development

Table 104. Qizheng Company Details

Table 105. Qizheng Business Overview

Table 106. Qizheng Transdermal Drug Delivery System Product

Table 107. Qizheng Revenue in Transdermal Drug Delivery System Business (US$ Million), 2021–2026

Table 108. Qizheng Recent Development

Table 109. Endo Company Details

Table 110. Endo Business Overview

Table 111. Endo Transdermal Drug Delivery System Product

Table 112. Endo Revenue in Transdermal Drug Delivery System Business (US$ Million), 2021–2026

Table 113. Endo Recent Development

Table 114. Huarun 999 Company Details

Table 115. Huarun 999 Business Overview

Table 116. Huarun 999 Transdermal Drug Delivery System Product

Table 117. Huarun 999 Revenue in Transdermal Drug Delivery System Business (US$ Million), 2021–2026

Table 118. Huarun 999 Recent Development

Table 119. Haw Par Company Details

Table 120. Haw Par Business Overview

Table 121. Haw Par Transdermal Drug Delivery System Product

Table 122. Haw Par Revenue in Transdermal Drug Delivery System Business (US$ Million), 2021–2026

Table 123. Haw Par Recent Development

Table 124. Nichiban Company Details

Table 125. Nichiban Business Overview

Table 126. Nichiban Transdermal Drug Delivery System Product

Table 127. Nichiban Revenue in Transdermal Drug Delivery System Business (US$ Million), 2021–2026

Table 128. Nichiban Recent Development

Table 129. Mentholatum Company Details

Table 130. Mentholatum Business Overview

Table 131. Mentholatum Transdermal Drug Delivery System Product

Table 132. Mentholatum Revenue in Transdermal Drug Delivery System Business (US$ Million), 2021–2026

Table 133. Mentholatum Recent Development

Table 134. Laboratoires Genevrier Company Details

Table 135. Laboratoires Genevrier Business Overview

Table 136. Laboratoires Genevrier Transdermal Drug Delivery System Product

Table 137. Laboratoires Genevrier Revenue in Transdermal Drug Delivery System Business (US$ Million), 2021–2026

Table 138. Laboratoires Genevrier Recent Development

Table 139. Research Programs/Design for This Report

Table 140. Key Data Information from Secondary Sources

Table 141. Key Data Information from Primary Sources

Table 142. Authors List of This Report

List of Figures

Figure 1. Transdermal Drug Delivery System Picture

Figure 2. Global Transdermal Drug Delivery System Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Transdermal Drug Delivery System Market Share by Type: 2025 vs 2032

Figure 4. Fentanyl Features

Figure 5. Nitroglycerin Features

Figure 6. Estradiol Features

Figure 7. Nicotine Features

Figure 8. Other Features

Figure 9. Global Transdermal Drug Delivery System Market Size by Application (US$ Million), 2021–2032

Figure 10. Global Transdermal Drug Delivery System Market Share by Application: 2025 vs 2032

Figure 11. OTC Case Studies

Figure 12. Rx Case Studies

Figure 13. Transdermal Drug Delivery System Report Years Considered

Figure 14. Global Transdermal Drug Delivery System Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 15. Global Transdermal Drug Delivery System Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 16. Global Transdermal Drug Delivery System Market Share by Region: 2025 vs 2032

Figure 17. Global Transdermal Drug Delivery System Market Share by Players in 2025

Figure 18. Global Transdermal Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 19. The Top 10 and 5 Players Market Share by Transdermal Drug Delivery System Revenue in 2025

Figure 20. North America Transdermal Drug Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 21. North America Transdermal Drug Delivery System Market Share by Country (2021–2032)

Figure 22. United States Transdermal Drug Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Canada Transdermal Drug Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe Transdermal Drug Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. Europe Transdermal Drug Delivery System Market Share by Country (2021–2032)

Figure 26. Germany Transdermal Drug Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. France Transdermal Drug Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. U.K. Transdermal Drug Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Italy Transdermal Drug Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Russia Transdermal Drug Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Ireland Transdermal Drug Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific Transdermal Drug Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Asia-Pacific Transdermal Drug Delivery System Market Share by Region (2021–2032)

Figure 34. China Transdermal Drug Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Japan Transdermal Drug Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. South Korea Transdermal Drug Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Southeast Asia Transdermal Drug Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. India Transdermal Drug Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Australia & New Zealand Transdermal Drug Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America Transdermal Drug Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Latin America Transdermal Drug Delivery System Market Share by Country (2021–2032)

Figure 42. Mexico Transdermal Drug Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Brazil Transdermal Drug Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa Transdermal Drug Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Middle East & Africa Transdermal Drug Delivery System Market Share by Country (2021–2032)

Figure 46. Israel Transdermal Drug Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Saudi Arabia Transdermal Drug Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. UAE Transdermal Drug Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Hisamitsu Revenue Growth Rate in Transdermal Drug Delivery System Business (2021–2026)

Figure 50. Mylan Revenue Growth Rate in Transdermal Drug Delivery System Business (2021–2026)

Figure 51. GSK Revenue Growth Rate in Transdermal Drug Delivery System Business (2021–2026)

Figure 52. Novartis Revenue Growth Rate in Transdermal Drug Delivery System Business (2021–2026)

Figure 53. Teve (Actavis) Revenue Growth Rate in Transdermal Drug Delivery System Business (2021–2026)

Figure 54. Johnson & Johnson Revenue Growth Rate in Transdermal Drug Delivery System Business (2021–2026)

Figure 55. Lohmann Revenue Growth Rate in Transdermal Drug Delivery System Business (2021–2026)

Figure 56. Teikoku Seiyaku Revenue Growth Rate in Transdermal Drug Delivery System Business (2021–2026)

Figure 57. Bayer Revenue Growth Rate in Transdermal Drug Delivery System Business (2021–2026)

Figure 58. Lingrui Revenue Growth Rate in Transdermal Drug Delivery System Business (2021–2026)

Figure 59. Sanofi Revenue Growth Rate in Transdermal Drug Delivery System Business (2021–2026)

Figure 60. Qizheng Revenue Growth Rate in Transdermal Drug Delivery System Business (2021–2026)

Figure 61. Endo Revenue Growth Rate in Transdermal Drug Delivery System Business (2021–2026)

Figure 62. Huarun 999 Revenue Growth Rate in Transdermal Drug Delivery System Business (2021–2026)

Figure 63. Haw Par Revenue Growth Rate in Transdermal Drug Delivery System Business (2021–2026)

Figure 64. Nichiban Revenue Growth Rate in Transdermal Drug Delivery System Business (2021–2026)

Figure 65. Mentholatum Revenue Growth Rate in Transdermal Drug Delivery System Business (2021–2026)

Figure 66. Laboratoires Genevrier Revenue Growth Rate in Transdermal Drug Delivery System Business (2021–2026)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Transdermal Adhesive Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pain Relief Patches Market Research Report 2025

Pain Relieving Patches Market

Transdermal Medical Patch Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Topical Pain Relief Patch Market Research Report 2024

Global Transdermal Transmucosal Drug Delivery System Market Insights Forecast to 2030

Global Microneedle Patch Transdermal Drug Delivery Systems Market Research Report 2025

Transdermal Therapeutic Systems TTS Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Transdermal Adhesives Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Transdermal Gel Market Research Report 2024

Global Microarray Patch Transdermal Drug Delivery Systems Market Research Report 2025

Global Adhesive Solutions for Drug Delivery Polymer Market Research Report 2024

Transdermal Drug Delivery Patches Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Transdermal Patch for Pain Relief Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Medical Transdermal Patch Market Research Report 2025

Global Transdermal Patch Testing System Market Research Report 2024

Transdermal Drug Delivery Formulation Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Transdermal and Transmucosal Drug Delivery Market Research Report 2024

Global Targeted Drug Delivery System Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions